Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF.

@article{Polansk2006EffectOR,
  title={Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF.},
  author={Kamila Polansk{\'a} and Karel Opatrn{\'y} and Richard Rokyta and Ale{\vs} Krou{\vz}eck{\'y} and Ladislav V{\'i}t and Eduard Kasal},
  journal={Renal failure},
  year={2006},
  volume={28 2},
  pages={107-18}
}
This study was designed to assess the principal markers of thrombogenicity and biocompatibility during continuous veno-venous hemodiafiltration (CVVHDF) using regional citrate anticoagulation (RCA). In a prospective study, 11 procedures with a polysulfone membrane were performed in nine critically ill patients with acute renal failure and impaired hemostasis. Blood samples were taken before and during CVVHDF at diafilter outlet--before calcium-induced reversal of the effect of citrate--at 15… CONTINUE READING